Freya Pharma Solutions Announces Response from the FDA on its US Clinical Development Program of LybridoTM for the treatment of Female Sexual Interest/Arousal Disorder ...Middle East

AMSTERDAM, June 19, 2023 /PRNewswire/ -- Freya Pharma Solutions, a pharmaceutical company dedicated to developing effective pharmaceutical therapies for women diagnosed with Female Sexual Disorders (FSD), announced today that the United States (US) Food and Drug Administration (FDA) has...

Hence then, the article about freya pharma solutions announces response from the fda on its us clinical development program of lybridotm for the treatment of female sexual interest arousal disorder was published today ( Monday 19/06/2023 - 12:13 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Freya Pharma Solutions Announces Response from the FDA on its US Clinical Development Program of LybridoTM for the treatment of Female Sexual Interest/Arousal Disorder )

Also on site :

• ‘We can insure the ship, but we cannot insure a human life.’
• Israel’s military posted two images of Ali Choeib in what it said was a Hezbollah uniform. One was fake.
• China conducts patrols in disputed area of ​​the South China Sea